Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II versus noradrenaline for perioperative hypotension in cardiac surgery
ACTRN12623000848606Phase 3Recruiting
- Sponsor
- Alfred Health
- Start
- Jan 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 2
01
Overview
Phase 3 trial of Angiotensin II and norepinephrine in hypotension (2 arms), sponsored by Alfred Health. Primary endpoint: Duration of hospital stay. Started Jan 2026; status: recruiting.
02
Drugs
Angiotensin IInorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on ACTRN12623000848606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000848606.